Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Renfu Likang Pharmaceutical is a specialized pharmaceutical company and a core subsidiary of the Humanwell Healthcare Group, based in Wuhan, China. The company focuses on the development, manufacturing, and distribution of chemical drugs, with a particular emphasis on the digestive and respiratory therapeutic areas. Its commercial portfolio features key products such as Racecadotril for the treatment of acute diarrhea and Ambroxol Hydrochloride for respiratory mucus clearance. Operating under strict GMP standards, the company leverages Humanwell's extensive R&D infrastructure to produce high-quality generic and specialized formulations. Renfu Likang plays a vital role in the parent group's domestic market strategy, providing essential medicines to hospitals and pharmacies across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 武汉人福利康药业.